Krystal Biotech, Inc. (KRYS) Ownership

NASDAQ Currency in USD Disclaimer

$158.52

south_east -$2.31 (-1.44%)
Day's range
$156.69
Day's range
$162.11

Krystal Biotech, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2024 4.29 M $781.43 M   0.21% 14.95%
BLACKROCK FUNDING, INC. /DE 11/13/2024 3.99 M $726.87 M   100.00% 13.91%
VANGUARD GROUP INC 11/13/2024 2.85 M $518.74 M   -0.68% 9.92%
AVORO CAPITAL ADVISORS LLC 11/14/2024 2.62 M $477.32 M   7.78% 9.13%
STATE STREET CORP 11/14/2024 1.45 M $264.46 M   9.00% 5.06%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/15/2024 988,460 $179.93 M   0.00% 3.44%
CAPITAL WORLD INVESTORS 11/13/2024 879,083 $160.02 M   0.11% 3.06%
REDMILE GROUP, LLC 11/14/2024 810,245 $147.49 M   -20.65% 2.82%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 600,261 $109.26 M   3.41% 2.09%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 591,631 $107.71 M   1.97% 2.06%
HOOD RIVER CAPITAL MANAGEMENT LLC 11/14/2024 502,104 $91.40 M   -3.64% 1.75%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 438,259 $79.78 M   -26.97% 1.53%
JENNISON ASSOCIATES LLC 11/08/2024 410,057 $74.64 M   -21.20% 1.43%
INVESCO LTD. 11/12/2024 365,551 $66.54 M   32.89% 1.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 313,200 $57.01 M   176.19% 1.09%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 311,855 $56.77 M   -7.23% 1.09%
GOLDMAN SACHS GROUP INC 11/14/2024 301,354 $54.86 M   -28.65% 1.05%
LORD, ABBETT & CO. LLC 12/13/2024 284,159 $51.73 M   -27.55% 0.99%
MORGAN STANLEY 11/14/2024 275,804 $50.20 M   -13.36% 0.96%
FRANKLIN RESOURCES INC 11/27/2024 243,760 $43.77 M   34.24% 0.85%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 240,216 $43.73 M   8.97% 0.84%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2024 216,979 $39.50 M   72.21% 0.76%
WOODLINE PARTNERS LP 11/14/2024 179,815 $32.73 M   -38.40% 0.63%
BANK OF NEW YORK MELLON CORP 11/12/2024 171,653 $31.25 M   -11.41% 0.60%
BAKER BROS. ADVISORS LP 11/14/2024 169,934 $30.93 M   0.00% 0.59%
BRAIDWELL LP 11/14/2024 168,691 $30.71 M   57.39% 0.59%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2024 163,304 $29.73 M   37.52% 0.57%
SEGALL BRYANT & HAMILL, LLC 11/08/2024 157,144 $28.60 M   352.38% 0.55%
C WORLDWIDE GROUP HOLDING A/S 11/05/2024 135,809 $24.72 M   0.00% 0.47%
JPMORGAN CHASE & CO 11/08/2024 127,901 $23.28 M   -21.93% 0.45%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 11/07/2024 126,082 $22.95 M   -34.17% 0.44%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 122,300 $22.26 M   13.35% 0.43%
PRINCIPAL FINANCIAL GROUP INC 10/31/2024 119,726 $21.79 M   -3.03% 0.42%
PICTET ASSET MANAGEMENT HOLDING SA 11/12/2024 115,350 $21.00 M   -16.07% 0.40%
TIMESSQUARE CAPITAL MANAGEMENT, LLC 11/04/2024 114,222 $20.79 M   37.55% 0.40%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 10/18/2024 111,705 $20.33 M   -36.69% 0.39%
BANK OF AMERICA CORP /DE/ 11/14/2024 104,654 $19.05 M   11.78% 0.36%
VICTORY CAPITAL MANAGEMENT INC 11/05/2024 98,285 $17.89 M   -31.68% 0.34%
EVENTIDE ASSET MANAGEMENT, LLC 11/14/2024 95,781 $17.44 M   -29.82% 0.33%
HANDELSBANKEN FONDER AB 10/04/2024 94,700 $17.24 M   -11.08% 0.33%
AMERIPRISE FINANCIAL INC 11/14/2024 89,749 $16.34 M   -12.01% 0.31%
S SQUARED TECHNOLOGY, LLC 11/14/2024 75,215 $13.69 M   -11.74% 0.26%
DECHENG CAPITAL LLC 11/15/2024 71,772 $13.06 M   9.12% 0.25%
RHUMBLINE ADVISERS 11/12/2024 70,309 $12.80 M   -1.92% 0.24%
VOYA INVESTMENT MANAGEMENT LLC 11/14/2024 68,444 $12.46 M   -6.08% 0.24%
LEGAL & GENERAL GROUP PLC 11/14/2024 68,164 $12.41 M   3.12% 0.24%
FIRST TURN MANAGEMENT, LLC 11/07/2024 67,942 $12.37 M   -37.79% 0.24%
EAGLE ASSET MANAGEMENT INC 11/12/2024 63,602 $12.70 M   -16.60% 0.22%
BARCLAYS PLC 11/19/2024 56,540 $10.29 M   196.21% 0.20%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2024 55,861 $10.17 M   -47.09% 0.19%

Krystal Biotech, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of KRYS shares?

During the previous two years, 308 institutional investors and hedge funds held shares of Krystal Biotech, Inc.. The most heavily invested institutionals were:

FMR LLC: 4.29 M

BlackRock Funding, Inc. /DE: 3.99 M

VANGUARD GROUP INC: 2.85 M

Avoro Capital Advisors LLC: 2.62 M

STATE STREET CORP: 1.45 M

Frazier Life Sciences Management, L.P.: 988,460

What percentage of Krystal Biotech, Inc. stock is owned by institutional investors?

97.50% of Krystal Biotech, Inc. stock is owned by institutional investors.

How much institutional buying is happening at KRYS ?

Institutional investors have bought a total of 32.96 M shares in the last 24 months. This purchase volume represents approximately $5.22 B in transactions.